10.1016/j.jbspin.2025.105889 |
40.096.884 |
Bardin, T ; Nguyen, QD ; Bausson, V ; Tran, K ; Dalbeth, N ; Tran, C & al |
Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective study. |
Joint Bone Spine |
2025 |
|
105889 |
10.1016/j.semarthrit.2025.152660 |
39.978.288 |
Gérard, AL ; Vieira, M ; Cohen, A ; Hassanaly, O ; Lambert, J ; Saadoun, D |
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals” Public Assistance. |
Semin Arthritis Rheum |
2025 |
71 |
152660 |
10.1007/s00701-024-06409-z |
39.891.775 |
Nataf, F ; Scher, N ; Bollet, M ; Mulier, G ; Birladeanu, A ; Sopanda, L & al |
Improving methodology of radiosurgery for posterior fossa cavernomas: higher volume, lower dose. |
Acta Neurochir (Wien) |
2025 |
167 |
29 |
10.1182/blood.2024026230 |
39.841.461 |
Perrot, A ; Touzeau, C ; Lambert, J ; Hulin, C ; Caillot, D ; Karlin, L & al |
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial. |
Blood |
2025 |
|
|
10.1002/hem3.70081 |
39.840.381 |
Marouf, A ; Chaubard, S ; Liévin, R ; Michot, JM ; Molinari, N ; Rossignol, J & al |
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA. |
Hemasphere |
2025 |
9 |
e70081 |
10.1016/j.jaut.2025.103360 |
39.826.312 |
Espitia, O ; Bruneval, P ; Liozon, E ; Pouchot, J ; de Boysson, H ; Gaudric, J & al |
Histological pattern of non-infectious thoracic aortitis impacts mortality. |
J Autoimmun |
2025 |
151 |
103360 |
10.1016/j.jeph.2024.202805 |
39.826.203 |
Mulier, G ; Ghosn, W ; Martin, D ; Hebbache, Z ; Coudin, E ; Fresson, J & al |
Neonatal mortality in 2001-2017 in France: A cause-specific and spatiotemporal analysis. |
J Epidemiol Popul Health |
2025 |
73 |
202805 |
10.1016/S2665-9913(24)00298-4 |
39.706.212 |
Farge, D ; Biard, L ; Weil, B ; Girault, V ; Lansiaux, P ; Munia, I & al |
Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study. |
Lancet Rheumatol |
2025 |
7 |
e261-e273 |
10.1007/s00277-024-06076-1 |
39.499.299 |
Tomowiak, C ; Poulain, S ; Nudel, M ; Feugier, P ; Herbaux, C ; Mahé, B & al |
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström”s macroglobulinemia. |
Ann Hematol |
2025 |
104 |
685-690 |
10.1093/rheumatology/keae331 |
38.970.381 |
Bletry, D ; Meyblum, L ; Desseaux, K ; Vautier, M ; Chiche, L ; Le Joncour, A & al |
Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis. |
Rheumatology (Oxford) |
2025 |
64 |
675-681 |